“Remdesivir for COVID-19” Study accidentally proved effectiveness of Hydroxychloroquine

The use of Remdesivir for COVID-19 was authorized by the FDA based on a single RCT, conducted by NIAID with the participation of Gilead Sciences, the exclusive manufacturer of Remdesivir. A final r…

Read the full article here

Related Articles